American College of Toxicology (ACT) 2017 Nov 5, 2017 20171105 Nov 8, 2017 Palm Springs Convention Center: 277 N Avenida Caballeros, Palm Springs, USA The American College of Toxicology's 38th Annual Meeting will be held November 5–8, 2017 at the Palm Springs Convention Center in the sun-drenched desert oasis, Palm Springs California. ACT's Annual Meeting provides the ideal venue for keeping abreast of emerging trends in the discipline of toxicology, for staying connected with friends and colleagues, and for making new connections. The Program is designed by and for members with the goal of providing excellent quality scientific and regulatory content that is directly applicable to the daily practice of toxicology. ACT is a professional society with an ideal size and culture providing consistent appeal to those who enjoy interacting personally with speakers, Council, and other colleagues in the field. /content/dam/pmiscience/default-fallback-thumbnails/conference/pmi-science-product-3840x2160.jpg

      American College of Toxicology (ACT) 2017

      Date
      Nov 5, 2017 - Nov 8, 2017
      Location
      Palm Springs Convention Center: 277 N Avenida Caballeros, Palm Springs, USA
      The American College of Toxicology's 38th Annual Meeting will be held November 5–8, 2017 at the Palm Springs Convention Center in the sun-drenched desert oasis, Palm Springs California. ACT's Annual Meeting provides the ideal venue for keeping abreast of emerging trends in the discipline of toxicology, for staying connected with friends and colleagues, and for making new connections. The Program is designed by and for members with the goal of providing excellent quality scientific and regulatory content that is directly applicable to the daily practice of toxicology. ACT is a professional society with an ideal size and culture providing consistent appeal to those who enjoy interacting personally with speakers, Council, and other colleagues in the field.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.